Suppliers / Kwality Pharmaceuticals

Kwality Pharmaceuticals

India 197 employees Updated 9 July 2026

Kwality Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 172 regulatory filings across 10 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), DIGEMAPS (DO) and NAFDAC (NG). Its GMP standing is certified by NAFDAC (NG), ANVISA (Brazil) and MCAZ (ZW), among 5 authorities. Customs aggregates show $24.3M of exports covering 2,287 molecules to 74 destinations in 2025.

0
active US DMFs
0
valid CEPs
6
registered plants
172
filings across 10 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Punjab, United Arab Emirates Not on file
HIMACHAL PRADESH, India Not on file
PUNJAB, India Not on file
Kangra (H.P.), India Not on file
Amritsur, India Not on file
AMRITSAR, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
ARCSA (EC) 57 None
DIGEMAPS (DO) 48 None
NAFDAC (NG) 37 3
MINSA (CR) 14 None
UZPHARM (UZ) 7 None
INVIMA (CO) 3 None
ANVISA (Brazil) None 3
MCAZ (ZW) None 3
EMA None 2
FDA (GH) None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $6.2M 41
2025 Not reported $24.3M 74
2024 Not reported $22.6M 72
2023 Not reported $20.0M 65

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Kwality Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts